Autologous Tumour Vaccine Trial
NCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 06923761 Brief Summary This is a Phase I/II, open-label, first-in human…
Read more arrow_forwardNCT 05607498 Brief Summary For solid tumors and lymphoma, respectively: This study…
Read more arrow_forwardNCT 06554795 Brief Summary A Phase 1/2a First-in-Human Study of DB-1419 in…
Read more arrow_forwardNCT 06824155 Brief Summary This is a first-in-human, Phase 0/1, open-label study…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forward